Penumbra Price to Book Ratio 2014-2022 | PEN
Historical price to book ratio values for Penumbra (PEN) over the last 10 years. The current price to book ratio for Penumbra as of February 03, 2023 is 10.18.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Penumbra Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-02-03 |
261.02 |
|
10.18 |
| 2022-09-30 |
189.60 |
$25.65 |
7.39 |
| 2022-06-30 |
124.52 |
$25.60 |
4.86 |
| 2022-03-31 |
222.13 |
$25.47 |
8.72 |
| 2021-12-31 |
287.32 |
$25.39 |
11.32 |
| 2021-09-30 |
266.50 |
$18.33 |
14.54 |
| 2021-06-30 |
274.06 |
$18.41 |
14.89 |
| 2021-03-31 |
270.58 |
$17.83 |
15.18 |
| 2020-12-31 |
175.00 |
$17.51 |
9.99 |
| 2020-09-30 |
194.38 |
$17.07 |
11.39 |
| 2020-06-30 |
178.82 |
$17.29 |
10.34 |
| 2020-03-31 |
161.33 |
$13.92 |
11.59 |
| 2019-12-31 |
164.27 |
$13.87 |
11.84 |
| 2019-09-30 |
134.49 |
$13.38 |
10.06 |
| 2019-06-30 |
160.00 |
$13.06 |
12.25 |
| 2019-03-31 |
147.01 |
$12.63 |
11.64 |
| 2018-12-31 |
122.20 |
$12.27 |
9.96 |
| 2018-09-30 |
149.70 |
$11.86 |
12.62 |
| 2018-06-30 |
138.15 |
$12.37 |
11.17 |
| 2018-03-31 |
115.65 |
$12.11 |
9.55 |
| 2017-12-31 |
94.10 |
$11.89 |
7.92 |
| 2017-09-30 |
90.30 |
$11.31 |
7.98 |
| 2017-06-30 |
87.75 |
$11.04 |
7.95 |
| 2017-03-31 |
83.45 |
$11.11 |
7.51 |
| 2016-12-31 |
63.80 |
$8.57 |
7.45 |
| 2016-09-30 |
75.99 |
$8.02 |
9.47 |
| 2016-06-30 |
59.50 |
$7.97 |
7.46 |
| 2016-03-31 |
46.00 |
$7.75 |
5.93 |
| 2015-12-31 |
53.81 |
$7.78 |
6.92 |
| 2015-09-30 |
40.10 |
$7.65 |
5.24 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$9.913B |
$0.748B |
|
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|
